Synthesis of aromatic lactone analogues of Lipoxin A4

Objective

Synthesis of novel aromatic Lipoxin A4 lactone analogues.

Results

Novel para-substituted aromatic lactone analogues of Lipoxin A4 have been synthesized in a convergent manner with six steps in the longest linear sequence in 12–13% yields, employing 2-deoxy-d-ribose as a chiral pool starting material and the classical E-selective Wittig olefination.

Lipoxins (LXs) are naturally occurring oxygenated derivatives of arachidonic acid that are produced and act at sites of inflammation [1,2,3,4,5,6]. Lipoxin A4 (LXA4) and Lipoxin B4 (LXB4) were first reported by Serhan and Samuelsson in 1984 [7]. They are biosynthesized from arachidonic acid via lipoxygenases and both LXA4 and LXB4 are known to exhibit potent and selective anti-inflammatory activity. Even though LXs play a vital role in the resolution of inflammation, their use in therapeutics is compromised because of their rapid metabolism [8,9,10,11]. This instability dramatically reduces the potential of LXs to be used as pharmacological agents, thus providing the impetus for us and others to develop syntheses of more stable analogues.

In recent decades, significant progress has been made in the synthesis of lipoxin-analogues. In the first reported synthesis by Petasis et al., the triene core of LXA4 was replaced by a more stable benzene ring, which introduced metabolic stability while conserving crucial biological activity [12, 13]. A stereoselective synthesis of aromatic LXA4 and LXB4 was reported by O’Sullivan et al. where they utilized a series of advanced reactions (Sharpless epoxidation, Pd-mediated Heck coupling and diastereoselective reductions) to achieve the desired stereochemistry. The resulting analogs exhibited increased phagocytotic activity compared to the native LXA4 [6]. A number of other synthetic strategies have also been reported [14,15,16,17,18,19,20,21]. In this paper, we describe a different and potentially more flexible approach to the synthesis of aromatic lipoxin analogues in their lactone forms using simple and available starting materials and the classical Wittig olefination to craft the central double bond. This research note reports on the performance of our synthetic approach to two novel lipoxin A4 analogues.

Results and discussion

We envisioned a synthetic strategy as outlined in Fig. 1A in which the aliphatic side chain would be connected via Friedel-Craft acylation and phenolate alkylation to generate the ketone and ether analogues 1 and 2, respectively. The chiral diol moiety can be harvested from the chiral pool via an enantiomerically pure, commercially available 2-deoxy-D-ribose. The central double bond could be crafted via an E-selective Wittig-olefination.

A Key synthetic strategies towards the target lactones. B Synthesis of key intermediate 7; a) 2,2-dimethoxypropane, DMF, MS 5 Å, 0 °C, 3 h, then rt overnight, 41%; b) Ph₃PCHCO₂Et, benzoic acid, toluene, reflux, 87%; c) H₂ (1 atm), Pd/C, EtOAc, rt, 93%; d) SO₃-Pyr, Et₃N/DMSO, DCM, rt, 87%. C Synthesis of key phosphonium salts 12 and 17; e) Heptanoyl chloride, AlCl₃, DCM, 0 °C, r.t, 30 min – 1 h, 73%; f) NBS, THF, H₂O, hv, r.t, 83%; g) PPh₃, acetone, reflux, 3 h, 82%. h) Heptyl bromide, K₂CO₃, CH₃CN, 24 h, reflux, 72%, or; KOH, EtOH, H₂O, 24 h, reflux, 76%; i) NBS, Bz₂O₂, DCM, reflux, 9 h, 48%. j) = g), 72%

Full size image

The chiral pool fragment is introduced from aldehyde 7 (Fig. 1B), set up for the key Wittig olefination, which was synthesized starting from commercial 2-deoxy-D-ribose (3). In a four-step procedure, protecting the diol moiety as a cyclic acetal via acid-catalysis, followed by a tandem ring-opening/Wittig olefination, Pd-catalyzed hydrogenation of the α, β-unsaturated double bond and a Parikh-Doering oxidation of the resulting alcohol, the aldehyde 7 was formed in overall 29% yield from 3. The appropriate phosphonium salts for the key Wittig olefination (12 and 17) were generated from toluene (8) and p-cresol (13), respectively (Fig. 1C). 8 was subjected to Friedel-Craft acylation with heptanoyl chloride, followed by light-induced benzylic radical bromination and subsequent nucleophilic displacement with triphenylphosphine to generate ketone 12 in 50% yield over 3 steps. 13 was treated with hexyl bromide and base, followed by benzylic bromination with N-bromosuccinimide (NBS) and the final nucleophilic displacement with triphenylphosphine to form phosphonium salt 17 in overall 26% over 3 steps. The typical Wohl-Ziegler benzylic mono-bromination could not be achieved in the system with the electron-donating alkoxy-group. An acceptable conversion to the benzylic bromide was achieved with NBS and a catalytic amount of dibenzoyl peroxide in the presence of dichloromethane (48% yield). A number of reported conditions for phosphonium salt formation initially failed for the formation of 17 but, it was found that a relatively short reaction time (3 h in refluxing acetone) was crucial to achieve 72% yield in this step.

The phosphonium salts 12 and 17 were treated with base and the resulting ylenes coupled with aldehyde 7 in Wittig olefinations to yield the desired products 18 and 19 in 60% and 61% yields respectively (Fig. 2). We were unable to extract the E/Z-ratios from the Wittig olefination steps from the raw data but minor peaks appear in spectra of purified materials. The final removal of the acetal group from both 18 and 19 under acidic conditions gave 70% and 75% yields of the target lactones 1 and 2, respectively. The unprotected diol esters were not detected directly but are likely intermediates in the formation of the lactones via spontaneous cyclization.

a K₂CO₃, THF, 0 °C, 1h – r.t. , 60%; b K₂CO₃, THF, 0 °C, 1h – r.t, 61%; c 1N HCl, THF, 0 °C - r.t. , 70%. d 1N HCl, THF, 0 °C - r.t, 75%

Full size image

In summary, we have successfully synthesized two novel trans-substituted aromatic lactone analogues of Lipoxin A4 in a convergent manner with six steps in the longest linear sequence using simple transformations and affordable reagents in overall 12–13% yield.

Methods

All reagents and solvents were purchased from commercial sources. The progress of the reactions were monitored by thin-layer chromatography (TLC) using Merck pre-coated silica gel plates (60 F₂₅₄). The TLC plates were visualized using either ultraviolet light or by immersion in a solution of phosphomolybdic acid, followed by heating. For preparative purification, flash column chromatography was carried out using silica gel from Merck (Silica gel 60, 0.040–0.063 mm). The intermediates and products were characterized by NMR on a 400 MHz Bruker Avance III HD. Chemical shifts (δ) are reported in ppm relative to the residual solvent peak (CDCl₃: δ_H 7.26 and δ_C 77.16; methanol-d₄: δ_H 3.31 and δ_C 49.00, deuterium oxide: δ_H 4.79 and δ_C 49.00; DMSO-d₆ δ_H 2.51 and δ_C 39.52). The raw data was analysed with MestReNova (Version 10.0.2–15,465). High-resolution mass spectra were obtained on a Thermo electron LTQ Orbitrap XL spectrometer, which was operated in electrospray ionization mass spectrometry (ESI) mode. The data was analyzed with Thermo Scientific Xcalibur software. Infrared spectra were recorded on a Varian 700e FT-IR spectrometer and bands are reported in wavenumbers (cm⁻¹).

Detailed synthetic procedures and analytical data can be found in Additional file 1.

The initial protection of the chiral pool sugar 3 is difficult to achieve in high yields and is a weak point in this synthetic strategy. Moreover, the benzylic radical bromination of electron-rich aromatics is a clear limitation of the synthesis of the phosphonium salts. Alternative strategies for this could be considered, e.g. direct chloromethylation. A third limitation appears to be that isomers generated in the key Wittig olefination step are difficult to separate.

Spectroscopic data for all intermediates and final products can be found in a separate additional file and is also available from the corresponding author upon request.

LXs:

Lipoxins

LXA4:

Lipoxin A4

LXB4:

Lipoxin B4

DMF:

Dimethyl formamide

MS:

Molecular sieves

rt:

Room temperature

DMSO:

Dimethyl sulfoxide

DCM:

Dichloromethane

NBS:

N-Bromosuccinimide

THF:

Tetrahydrofuran

Bz:

Benzoyl

TLC:

Thin-Layer Chromatography

NMR:

Nuclear Magnetic Resonance

FT-IR:

Fourier Transform-Infrared Spectroscopy

The authors acknowledge preliminary investigations in the project conducted by Mr. Keven Mardy, Ms. Laura Krieger and Ms. Lina Malinauskaité. Assistance with NMR and mass spectrometry measurements was provided by Mr. Jostein Johansen and Dr. Truls Ingebrigtsen.

Open Access funding provided by UiT The Arctic University of Norway. The authors would like to acknowledge financial support for this project from the Department of Chemistry at UiT The Arctic University of Norway and the Olav Thon Foundation. The publication charges for this article have been funded by a Grant from the publication fund of UiT The Arctic University of Norway.

1. Aya Ismael and Muhammad Zeeshan contributed equally to the manuscript and are presented in alphabetical order

Authors and Affiliations

1. Department of Chemistry, Chemical Synthesis and Analysis Division, UiT The Arctic University of Norway, 9037, Tromsø, Norway

   Aya Ismael, Muhammad Zeeshan & Jørn H. Hansen

Contributions

AI and MZ contributed equally to this manuscript. AI and MZ conducted experiments, analyzed data and contributed to manuscript. JHH designed research, supervised experiments, analyzed data and contributed to manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jørn H. Hansen.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions